Find Industry reports, Company profilesReportLinker ...
Find Industry reports, Company profilesReportLinker an...
Find Industry reports, Company profilesReportLinker and Mark...
Find Industry reports, Company profilesReportLinker ...
Find Industry reports, Company profilesReportLinker ...
of 5

Nabi Biopharmaceuticals - Financial and Strategic Analysis Review

Nabi Biopharmaceuticals - Financial and Strategic Analysis ReviewSummaryNabi Biopharmaceuticals is a pharmaceutical company engaged in applying vaccine and antibody technologies to develop new products for unmet medical needs. It commercializes its products to dialysis centers, hospitals and physician specialties. The company principally focuses on the areas of nicotine addiction and infectious disease. It is headquartered in Rockville, Maryland of the United States. The company did not generate any revenues in the fiscal year ended December 2008. The operating loss of the company was $25.0 million during the fiscal year 2008, as compared to an operating loss of $44.9 million during 2007.Global Markets Direct's Nabi Biopharmaceuticals - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Nabi Biopharmaceuticals. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward. Scope- Provides key company information for business intelligence needs.- The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered. - The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted. - The report contains critical company information ' business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.Reasons to buy- A quick 'one-stop-shop' to understand the company.- Enhance business/sales activities by understanding customers' businesses better.- Get detailed information and financial and strategic analysis on companies operating in your industry.- Identify prospective partners and suppliers ' with key data on their businesses and locations.- Capitalize on competitor's weaknesses and target the market opportunities available to them.- Compare your company's financial trends with those of your peers / competitors.- Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Published on: Mar 3, 2016
Published in: Business      Economy & Finance      
Source: www.slideshare.net


Transcripts - Nabi Biopharmaceuticals - Financial and Strategic Analysis Review

  • 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Nabi Biopharmaceuticals - Financial and Strategic Analysis ReviewPublished on June 2009 Report SummaryNabi Biopharmaceuticals - Financial and Strategic Analysis ReviewSummaryNabi Biopharmaceuticals is a pharmaceutical company engaged in applying vaccine and antibody technologies to develop newproducts for unmet medical needs. It commercializes its products to dialysis centers, hospitals and physician specialties. Thecompany principally focuses on the areas of nicotine addiction and infectious disease. It is headquartered in Rockville, Maryland ofthe United States. The company did not generate any revenues in the fiscal year ended December 2008. The operating loss of thecompany was $25.0 million during the fiscal year 2008, as compared to an operating loss of $44.9 million during 2007.Global Markets Directs Nabi Biopharmaceuticals - Financial and Strategic Analysis Review is an in-depth business, strategic andfinancial analysis of Nabi Biopharmaceuticals. The report provides a comprehensive insight into the company, including businessstructure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis ofthe company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.Scope- Provides key company information for business intelligence needs.- The companys strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operationalfactors are considered.- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats arehighlighted.- The report contains critical company information business structure and operations, the company history, major products andservices, key competitors, key employees and executive biographies, different locations and important subsidiaries.- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.Reasons to buy- A quick one-stop-shop to understand the company.- Enhance business/sales activities by understanding customers businesses better.- Get detailed information and financial and strategic analysis on companies operating in your industry.- Identify prospective partners and suppliers with key data on their businesses and locations.- Capitalize on competitors weaknesses and target the market opportunities available to them.- Compare your companys financial trends with those of your peers / competitors.- Scout for potential acquisition targets, with detailed insight into the companies strategic, financial and operational performance.Nabi Biopharmaceuticals - Financial and Strategic Analysis Review Page 1/5
  • 2. Find Industry reports, Company profilesReportLinker and Market Statistics Table of ContentTable Of ContentsTable Of Contents 2List of Tables 3List of Figures 3Key Facts 4Business Description 4Major Products and Services 5History 5SWOT Analysis 6SWOT Analysis - Overview 6Nabi Biopharmaceuticals - Strengths 6Nabi Biopharmaceuticals - Strengths - Research and Development 6Nabi Biopharmaceuticals - Strengths - Increasing Sales of Xifaxan 6Nabi Biopharmaceuticals - Strengths - Strategic and Collaborative Agreements 6Nabi Biopharmaceuticals - Weaknesses 6Nabi Biopharmaceuticals - Weaknesses - Dependence on Third Party Manufacturers 6Nabi Biopharmaceuticals - Weaknesses - Pending Lawsuits 6Nabi Biopharmaceuticals - Opportunities 6Nabi Biopharmaceuticals - Opportunities - Gastrointestinal Disease Treatment Market 6Nabi Biopharmaceuticals - Opportunities - Inorganic Expansion 7Nabi Biopharmaceuticals - Opportunities - Approval of Colazal Capsules in ulcerative colitis 7Nabi Biopharmaceuticals - Opportunities - Emerging Markets 7Nabi Biopharmaceuticals - Opportunities - Rising Healthcare Expenditure in the US 7Nabi Biopharmaceuticals - Threats 7Nabi Biopharmaceuticals - Threats - Highly Competitive Markets 7Nabi Biopharmaceuticals - Threats - Pricing of Drugs 7Nabi Biopharmaceuticals - Threats - Product Liability 7Nabi Biopharmaceuticals - Threats - Stringent Regulatory Actions 7Key Competitors 9Key Employees 9Key Employee Biographies 9Locations And Subsidiaries 10Locations And Subsidiaries - Head Office 10Locations And Subsidiaries - Other Locations & Subsidiaries 10Financial Ratios 11Financial Ratios - Capital Market Ratios 11Financial Ratios - Annual Ratios 11Financial Ratios - Interim Ratios 11Financial Ratios - Ratio Charts 12Appendix 13Methodology 13Ratio Definitions 13Nabi Biopharmaceuticals - Financial and Strategic Analysis Review Page 2/5
  • 3. Find Industry reports, Company profilesReportLinker and Market StatisticsAbout Global Markets Direct 16Contact Us 16Disclaimer 16List of TablesNabi Biopharmaceuticals, Key Facts 4Major Products and Services 5Nabi Biopharmaceuticals, History 5Nabi Biopharmaceuticals, Key Employees 9Nabi Biopharmaceuticals, Key Employee Biographies 9Nabi Biopharmaceuticals, Other Locations 10Nabi Biopharmaceuticals, Ratios based on current share price 11Nabi Biopharmaceuticals, Annual Ratios 11Nabi Biopharmaceuticals, Interim Ratios 11Currency Codes 13Capital Market Ratios 13Equity Ratios 14Profitability Ratios 14Cost Ratios 14Liquidity Ratios 15Leverage Ratios 15Efficiency Ratios 15List of FiguresNabi Biopharmaceuticals, Ratio Charts 12Nabi Biopharmaceuticals - Financial and Strategic Analysis Review Page 3/5
  • 4. Find Industry reports, Company profilesReportLinker and Market Statistics Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Nabi Biopharmaceuticals - Financial and Strategic Analysis Review Product Formats Please select the product formats and the quantity you require. Digital Copy--USD 125.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________Nabi Biopharmaceuticals - Financial and Strategic Analysis Review Page 4/5
  • 5. Find Industry reports, Company profilesReportLinker and Market Statistics Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93Nabi Biopharmaceuticals - Financial and Strategic Analysis Review Page 5/5

Related Documents